U.S. Markets closed

What Is GlycoMimetics Inc’s (GLYC) Share Price Doing?

Frank Brewer

GlycoMimetics Inc (NASDAQ:GLYC), a biotechnology company based in United States, saw a significant share price rise of over 20% in the past couple of months on the NasdaqGM. As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. But what if there is still an opportunity to buy? Today I will analyse the most recent data on GLYC’s outlook and valuation to see if the opportunity still exists. Check out our latest analysis for GlycoMimetics

What’s the opportunity in GLYC?

GLYC appears to be overvalued by 28% at the moment, based on my discounted cash flow valuation. The stock is currently priced at $12.67 on the market compared to my intrinsic value of $9.87. This means that the opportunity to buy GLYC at a good price has disappeared! If you like the stock, you may want to keep an eye out for a potential price decline in the future. Given that GLYC’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

What kind of growth will GLYC generate?

NasdaqGM:GLYC Future Profit Nov 28th 17

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at GLYC future expectations. With profit expected to grow by 82.67% over the next couple of years, the future seems bright for GLYC. It looks like higher cash flows is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? GLYC’s optimistic future growth appears to have been factored into the current share price, with shares trading above its fair value. However, this brings up another question – is now the right time to sell? If you believe GLYC should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping tabs on GLYC for some time, now may not be the best time to enter into the stock. The price has surpassed its true value, which means there’s no upside from mispricing. However, the positive outlook is encouraging for GLYC, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on GlycoMimetics. You can find everything you need to know about GLYC in the latest infographic research report. If you are no longer interested in GlycoMimetics, you can use our free platform to see my list of over 50 other stocks with a high growth potential.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.